-
Ascletis Announces First Participants Dosed in U.S. Phase I Clinical Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor for the Treatment of Psoriasis
18 Jun 2025 00:32 GMT
… ASC50 for the treatment of psoriasis.
- Preclinical data, … and inflammatory diseases, including psoriasis.
The Phase I clinical … mild-to-moderate plaque psoriasis. ASC50 oral tablets are … -for-the-treatment-of-psoriasis-302484058.html
SOURCE Ascletis …
-
FDA Approves Steqeyma for Children With Plaque Psoriasis, Psoriatic Arthritis
17 Jun 2025 16:29 GMT
… kg and live with plaque psoriasis (PsO) or psoriatic arthritis (PsA … in moderate to severe plaque psoriasis: 28-week results of a …
-
S3 Episode 5: Smartphones and the Future of Psoriasis Care
17 Jun 2025 14:15 GMT
… digital assessment tools for psoriasis and psoriatic arthritis with … this was developed by Psoriasis and Psoriatic Arthritis Clinics … for Medscape's Psoriasis InDiscussion.
Listen to … of-Concept Study
Psorcast
Psoriasis and Psoriatic Arthritis Clinics …
-
FDA approves new presentation of Celltrion’s SteQeyma for paediatric psoriasis
17 Jun 2025 11:48 GMT
… treat paediatric patients with plaque psoriasis (PsO) or psoriatic arthritis … affected by some form of psoriasis, a chronic inflammatory condition … up to 90% of psoriasis patients and is characterised … , affecting around 30% of psoriasis patients.
The FDA’s …
-
Methotrexate Adds No Benefit to Adalimumab in Psoriasis Treatment, Study Suggests
17 Jun 2025 04:54 GMT
… conditions, such as arthritis and psoriasis.2 Previously, combining methotrexate and … was beneficial for treating plaque psoriasis,” wrote the researchers. “Future studies … vs adalimumab with methotrexate for psoriasis. JAMA Dermatol. Published online June …
-
Generalized Pustular Psoriasis May Have Higher Mortality than Plaque Psoriasis
17 Jun 2025 02:52 GMT
… patients with plaque psoriasis.
While distinct from plaque psoriasis, GPP often exhibits … general population without GPP or [psoriasis].”1
Investigators included patients with … in Generalized Pustular Psoriasis (GPP) than Plaque Psoriasis and the General …
-
FDA approves new presentation of ustekinumab-stba biosimilar for plaque psoriasis, psoriatic arthritis
16 Jun 2025 20:17 GMT
… with moderate-to-severe plaque psoriasis (candidates for phototherapy or systemic … treat moderate to severe plaque psoriasis. Contemporary Pediatrics. April 23, … as biosimilar for pediatric plaque psoriasis, active psoriatic arthritis. Contemporary …
-
Weight-Loss Surgery Linked to Psoriasis Remission in Over 97 Percent of Patients: Systematic Review Suggests
16 Jun 2025 17:17 GMT
… significantly improve or even resolve psoriasis symptoms in most individuals struggling … intervention could also positively influence psoriasis outcomes.
To evaluate this, … managing inflammatory skin conditions like psoriasis. However, the authors caution …
-
Psoriasis Linked to Increased Metabolic Syndrome Risk, Mediated by Disease Activity
16 Jun 2025 17:05 GMT
… 1
According to the National Psoriasis Foundation, 125 million people … a control group comprising non-psoriasis individuals
Clinical or pathological confirmation … #47;fmed.2025.1593003
National Psoriasis Foundation. Psoriasis Statistics. December 21, 2022 …
-
Psoriasis May Be a Protective Factor for Certain Forms of Cancer, Research Suggests
16 Jun 2025 17:05 GMT
… randomization (MR) study indicates psoriasis may be inversely associated with … 2020 indicated additional associations between psoriasis and lung cancer, bladder … confounders, as patients with psoriasis often receive immunomodulatory therapies that …